Updates

April 23, 2019April 23, 2019
Despite Benefits, Many IPF Patients Switching from Esbriet to Ofev Stop Treatment, Possibly Due to Low BMI, Study Says

Many patients with idiopathic pulmonary fibrosis (IPF) who are switching from Esbriet (pirfenidone) to Ofev (nintedanib) discontinue treatment, especially if they are underweight ... Read more
April 22, 2019April 22, 2019
PFF Summit 2019 in Texas to Present the Latest Research Affecting the PF Community

The pulmonary fibrosis (PF) community is invited to attend the Pulmonary Fibrosis Foundation‘s PFF Summit, which is the largest healthcare meeting on PF, ... Read more
April 18, 2019April 17, 2019
Lessons I’ve Learned Since My IPF Diagnosis 3 Years Ago

We learn the most important lessons in the most difficult times, and I’m grateful to have had opportunities to live those lessons and share ... Read more
April 17, 2019April 17, 2019
Rare Gene Variants Linked to Worse Lung Transplant Outcomes in PF Patients

Rare variants in genes that regulate the end regions of chromosomes — called telomeres — are linked with worse survival rates after lung ... Read more
April 17, 2019April 16, 2019
Finding Support While Going Through Difficult Times

Before receiving my official diagnosis of idiopathic pulmonary fibrosis (IPF), I was confident in my knowledge of it. Since it was suggested ... Read more

News

IPF Patients Live Longer on Ofev Compared with Placebo, Analysis Suggests
April 16, 2019April 16, 2019
Treatment with Ofev (nintedanib) can significantly extend the survival of patients with idiopathic pulmonary fibrosis ...
News

Northwestern Doctor Awarded ATS Foundation/Boehringer Ingelheim Fellowship for IPF Research
April 15, 2019April 15, 2019
The American Thoracic Society (ATS) Foundation and Boehringer Ingelheim have awarded a physician scientist at ...
News

10 Exercise Myths and Truths: Advice from a Respiratory Specialist
April 12, 2019
Myth 1: If you can’t run with the big dogs, stay on the porch. ...
News

Phase 1 Trial Testing PLN-74809 Supports its Clinical Development for IPF Treatment, Pliant Announces
April 12, 2019April 12, 2019
Pliant Therapeutics has successfully completed a Phase 1 clinical study assessing its investigational therapy ...
Columns, Younger than 30: Living with IPF, a column by Charlene Marshall

The ‘Logan Boulet Effect’ and Its Impact on Patients with PF
April 11, 2019April 18, 2019
Most Canadians will remember where they were when they heard the news of the ...
News

High Levels of Vimentin Protein Linked to Lung Fibrosis, Study Shows
April 10, 2019
High levels of the protein vimentin in the lung tissue of patients with idiopathic ...

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

Traveling by Air Again Following Lung Transplantation
April 10, 2019April 18, 2019
Several months after my lung transplant in 2015, my transplant team OK’d me to travel by ...
High Monocyte Levels Linked to Poorer Outcomes in IPF, Other Fibrotic Diseases, Study Finds
April 9, 2019April 18, 2019
Blood levels of immune cells called monocytes may help predict disease severity and determine ...
Secondary Insurance Coverage Boosts Adherence to Treatment with Ofev, Esbriet, Study Finds
April 8, 2019
What Are Your Priorities as a Patient with Pulmonary Fibrosis?
April 8, 2019April 5, 2019
Veracyte’s Envisia Classifier Improves ILD/IPF Diagnosis, Study Says
April 5, 2019April 5, 2019
Longing for Normalcy
April 4, 2019April 2, 2019

Our Family Came Through When My Caregiver Needed Caregiving
April 3, 2019April 2, 2019
After contracting respiratory syncytial virus (RSV) and having an exacerbation of my idiopathic pulmonary fibrosis, ...
Increased Honeycombing Areas a Prognostic Factor in IPF, Study Finds
April 3, 2019April 3, 2019
IPF Patients’ Quality of Life Linked to Lung Changes, Comorbidities, Disease’s Course
April 2, 2019April 2, 2019
Managing Stress As a Patient with PF: A Collective Response
April 1, 2019March 28, 2019

Vanderbilt University and TGen Awarded $6.1M in Federal Grants to Study Causes of Pulmonary Fibrosis
April 1, 2019April 1, 2019
Two federal grants totaling $6.1 million were awarded to Vanderbilt University Medical Center (VUMC) ...
Registration Open for Medical Centers with PF Expertise to Join PFF Care Center Network
March 29, 2019April 18, 2019
‘Five Feet Apart’ Hits Home for Patients With Pulmonary Fibrosis
March 28, 2019April 4, 2019

News

Oxygen Manifesto, Part 1: Advice from 3 Respiratory Specialists
March 27, 2019March 29, 2019
Note: This is the first part of a two-part series written in collaboration with ...
Columns, Gonna Live My Life by Mark Koziol

The Beauty of My Support Network
March 27, 2019March 25, 2019
In June 2016, Lifebanc held its Gift of Life Walk and Run alongside the Transplant Games ...
News

PRM-151 Receives FDA Breakthrough Therapy Designation for IPF Treatment
March 27, 2019March 27, 2019
The U.S. Food and Drug Administration has granted breakthrough therapy designation to PRM-151, a compound ...
Esbriet, News

Esbriet Safe and Effective for Patients with Advanced Idiopathic Pulmonary Fibrosis, Trial Suggests
March 26, 2019April 4, 2019
A post-hoc analysis of the Phase 3 RECAP trial shows that long-term treatment with ...
News

Protein that Drives Cancer Is Potential New Therapeutic Target for Idiopathic Pulmonary Fibrosis, Study Suggests
March 25, 2019March 27, 2019
High levels of PD-L1 protein were found in the most aggressive fibroblasts that drive ...
News

Broadway Belts For PFF! Raises Record $400,000 for PF Foundation
March 22, 2019March 28, 2019
This year’s edition of Broadway Belts For PFF! — a benefit event for the ...
Columns, Younger than 30: Living with IPF, a column by Charlene Marshall

Chronic Sorrow Is a Powerful Force in My Pulmonary Fibrosis Journey
March 21, 2019March 26, 2019
Following the diagnosis of a life-threatening illness, it is hard to put into words ...
Columns, Gonna Live My Life by Mark Koziol

IPF, Lung Transplant, and the Cleveland Browns
March 20, 2019March 22, 2019
I have been a season ticket holder with the Cleveland Browns football team since ...
News

Saracatinib, Potential Oral IPF Therapy, Granted Orphan Drug Status by FDA
March 20, 2019March 26, 2019
Saracatinib (AZD0530), an investigational oral therapy under development by AstraZeneca, was granted Orphan Drug ...
News

Study Finds Increased Risk of PF Among World Trade Center Responders
March 19, 2019March 22, 2019
Exposure to dust in the aftermath of the World Trade Center attacks increased the ...
Columns, Younger than 30: Living with IPF, a column by Charlene Marshall

How Various Groups Help to Sustain Me
March 18, 2019March 15, 2019
I believe that people enter our lives when we need them most. I have ...
News

Blockage of Cells’ Self-cleansing System Underlies Silica-induced PF, Study Suggests
March 18, 2019March 18, 2019
Exposure to silica dust may trigger pulmonary fibrosis (PF) because silica particles block a ...

April 27, 2018April 27, 2018

Aloperine May Protect Against Pulmonary Fibrosis in Mouse Model, Study Suggests

News

Treatment with plant-derived aloperine reduces the severity of lung injury in a mouse model of pulmonary fibrosis, a new Chinese study reports. The research, “Aloperine Protects Mice against Bleomycin-induced Pulmonary Fibrosis by Attenuating Fibroblast Proliferation and Differentiation,” was published ... Read more

Subscribe to our mailing list

Pin It on Pinterest